• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

以吲哚部分作为人腺苷A受体配体的腺苷类似物的合成。

Synthesis of adenosine analogues with indole moiety as human adenosine A receptor ligands.

作者信息

Xia Yan, Zheng Xiliang, Wang Erkang, Li Dongfeng, Hou Ruibin, Wang Jin

机构信息

State Key Laboratory of Electroanalytical Chemistry, Changchun Institute of Applied Chemistry Chinese Academy of Sciences, Renmen Street, Changchun 130022, People's Republic of China.

College of Chemistry and Life Science, Changchun University of Technology, Yanan Street No. 2055, Changchun 130012, People's Republic of China.

出版信息

R Soc Open Sci. 2018 Feb 7;5(2):171596. doi: 10.1098/rsos.171596. eCollection 2018 Feb.

DOI:10.1098/rsos.171596
PMID:29515872
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5830761/
Abstract

Adenosine is an endogenous modulator exerting its functions through the activation of four adenosine receptor (AR) subtypes, termed A, A, A and A, which belong to the G-protein-coupled receptor superfamily. The human AAR (hAAR) subtype is implicated in several cytoprotective functions. Therefore, hAAR modulators, and in particular agonists, are sought for their potential application as anti-inflammatory, anti-cancer and cardioprotective agents. Here, we prepared novel adenosine derivatives with indole moiety as hAAR ligands. According to the biological assay, we found that 2-substituents were critical structural determinants for AAR ligands ( = 111 nM). The observed structure-affinity relationships of this class of ligands were also exhaustively rationalized using the molecular modelling approach. This allows the investigation on the binding mode of the potential compound in the ligand-binding pocket of the human A receptor. The results demonstrated that can interact with the ASN250, GLN167, PHE168 and VAL178 through hydrogen bonding, which are shown to be important for ligand-receptor interaction.

摘要

腺苷是一种内源性调节剂,通过激活四种腺苷受体(AR)亚型发挥其功能,这四种亚型分别称为A1、A2A、A2B和A3,它们属于G蛋白偶联受体超家族。人类A2A受体(hA2AR)亚型与多种细胞保护功能有关。因此,人们正在寻找hA2AR调节剂,尤其是激动剂,以探索其作为抗炎、抗癌和心脏保护剂的潜在应用。在此,我们制备了具有吲哚部分的新型腺苷衍生物作为hA2AR配体。根据生物学测定,我们发现2-取代基是A2AR配体的关键结构决定因素(EC50 = 111 nM)。这类配体观察到的结构-亲和力关系也通过分子建模方法进行了详尽的合理化解释。这使得我们能够研究潜在化合物在人类A2A受体配体结合口袋中的结合模式。结果表明,[化合物名称未给出]可以通过氢键与ASN250、GLN167、PHE168和VAL178相互作用,这些被证明对配体-受体相互作用很重要。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4ec4/5830761/f2d975c7d3cd/rsos171596-g5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4ec4/5830761/3af18a525ab0/rsos171596-g1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4ec4/5830761/5bb431acaa48/rsos171596-g2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4ec4/5830761/f2d975c7d3cd/rsos171596-g5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4ec4/5830761/3af18a525ab0/rsos171596-g1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4ec4/5830761/5bb431acaa48/rsos171596-g2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4ec4/5830761/f2d975c7d3cd/rsos171596-g5.jpg

相似文献

1
Synthesis of adenosine analogues with indole moiety as human adenosine A receptor ligands.以吲哚部分作为人腺苷A受体配体的腺苷类似物的合成。
R Soc Open Sci. 2018 Feb 7;5(2):171596. doi: 10.1098/rsos.171596. eCollection 2018 Feb.
2
Structural Probing and Molecular Modeling of the A₃ Adenosine Receptor: A Focus on Agonist Binding.A₃ 腺苷受体的结构探测与分子建模:聚焦于激动剂结合
Molecules. 2017 Mar 11;22(3):449. doi: 10.3390/molecules22030449.
3
New substituted 9-alkylpurines as adenosine receptor ligands.新型取代的9-烷基嘌呤作为腺苷受体配体。
Bioorg Med Chem. 1998 May;6(5):523-33. doi: 10.1016/s0968-0896(98)00007-8.
4
Design and Synthesis of 2,6-Disubstituted-4'-Selenoadenosine-5'-,-Dimethyluronamide Derivatives as Human A Adenosine Receptor Antagonists.2,6-二取代-4'-硒代腺苷-5'-二甲基脲酰胺衍生物作为人A腺苷受体拮抗剂的设计与合成
Pharmaceuticals (Basel). 2021 Apr 14;14(4):363. doi: 10.3390/ph14040363.
5
Exploring the Role of N-Substituents in Potent Dual Acting 5'-C-Ethyltetrazolyladenosine Derivatives: Synthesis, Binding, Functional Assays, and Antinociceptive Effects in Mice ∇.探索N-取代基在强效双作用5'-C-乙基四唑基腺苷衍生物中的作用:合成、结合、功能测定及对小鼠的镇痛作用∇
J Med Chem. 2017 May 25;60(10):4327-4341. doi: 10.1021/acs.jmedchem.7b00291. Epub 2017 May 5.
6
A facile and novel synthesis of N(2)-, C(6)-substituted pyrazolo[3,4-d]pyrimidine-4 carboxylate derivatives as adenosine receptor antagonists.一种简便新颖的 N(2)-、C(6)-取代的吡唑并[3,4-d]嘧啶-4 羧酸酯衍生物的合成方法,作为腺苷受体拮抗剂。
Eur J Med Chem. 2015 Mar 6;92:784-98. doi: 10.1016/j.ejmech.2015.01.046. Epub 2015 Jan 22.
7
Discovery of simplified N²-substituted pyrazolo[3,4-d]pyrimidine derivatives as novel adenosine receptor antagonists: efficient synthetic approaches, biological evaluations and molecular docking studies.发现简化的N²-取代吡唑并[3,4-d]嘧啶衍生物作为新型腺苷受体拮抗剂:高效合成方法、生物学评价及分子对接研究
Bioorg Med Chem. 2014 Mar 1;22(5):1751-65. doi: 10.1016/j.bmc.2014.01.018. Epub 2014 Jan 31.
8
Substituted 4-phenylthiazoles: Development of potent and selective A, A and dual A/A adenosine receptor antagonists.取代 4-苯基噻唑类化合物:高效且选择性的 A₁A₂A 和 A₁/A₂腺苷受体拮抗剂的研发。
Eur J Med Chem. 2020 Jan 15;186:111879. doi: 10.1016/j.ejmech.2019.111879. Epub 2019 Nov 15.
9
Insight into the interactions between novel coumarin derivatives and human A3 adenosine receptors.新型香豆素衍生物与人 A3 腺苷受体相互作用的研究。
ChemMedChem. 2014 Oct;9(10):2245-53. doi: 10.1002/cmdc.201402205. Epub 2014 Jul 18.
10
2-Substituted N-ethylcarboxamidoadenosine derivatives as high-affinity agonists at human A3 adenosine receptors.2-取代的N-乙基羧酰胺基腺苷衍生物作为人A3腺苷受体的高亲和力激动剂。
Naunyn Schmiedebergs Arch Pharmacol. 1999 Aug;360(2):103-8. doi: 10.1007/s002109900044.

引用本文的文献

1
Anticancer Activity of Enantiomeric Neplanocins A: Exploring the Role of Chirality in Tumor Suppression.对映体新制癌菌素A的抗癌活性:探索手性在肿瘤抑制中的作用
Int J Mol Sci. 2025 Feb 4;26(3):1308. doi: 10.3390/ijms26031308.
2
Adenosine Derivates as Antioxidant Agents: Synthesis, Characterization, in Vitro Activity, and Theoretical Insights.作为抗氧化剂的腺苷衍生物:合成、表征、体外活性及理论见解
Antioxidants (Basel). 2019 Oct 9;8(10):468. doi: 10.3390/antiox8100468.

本文引用的文献

1
The A3 adenosine receptor: history and perspectives.A3 腺苷受体:历史与展望。
Pharmacol Rev. 2015;67(1):74-102. doi: 10.1124/pr.113.008540.
2
Roles of adenosine and its receptors in sleep-wake regulation.腺苷及其受体在睡眠-觉醒调节中的作用。
Int Rev Neurobiol. 2014;119:349-71. doi: 10.1016/B978-0-12-801022-8.00014-3.
3
Adenosine receptors in cerebral ischemia.脑缺血中的腺苷受体
Int Rev Neurobiol. 2014;119:309-48. doi: 10.1016/B978-0-12-801022-8.00013-1.
4
Synthesis and antiproliferative activity of conjugates of adenosine with muramyl dipeptide and nor-muramyl dipeptide derivatives.腺苷与胞壁酰二肽及去甲胞壁酰二肽衍生物缀合物的合成及其抗增殖活性
Bioorg Med Chem Lett. 2014 Aug 1;24(15):3587-91. doi: 10.1016/j.bmcl.2014.05.043. Epub 2014 May 23.
5
Adenosine and inflammation: what's new on the horizon?腺苷与炎症:地平线上有何新进展?
Drug Discov Today. 2014 Aug;19(8):1051-68. doi: 10.1016/j.drudis.2014.02.010. Epub 2014 Mar 6.
6
[Adenosine, its analogues and conjugates].
Postepy Hig Med Dosw (Online). 2013 Dec 3;67:1189-203. doi: 10.5604/17322693.1078588.
7
Discovery of novel A3 adenosine receptor ligands based on chromone scaffold.基于色酮骨架的新型 A3 腺苷受体配体的发现。
Biochem Pharmacol. 2012 Jul 1;84(1):21-9. doi: 10.1016/j.bcp.2012.03.007. Epub 2012 Mar 17.
8
Recent advances on A₃ adenosine receptor antagonists by QSAR tools.基于定量构效关系方法的 A₃ 腺苷受体拮抗剂的最新进展。
Curr Top Med Chem. 2012;12(8):878-94. doi: 10.2174/156802612800166792.
9
LigPlot+: multiple ligand-protein interaction diagrams for drug discovery.LigPlot+:用于药物发现的多种配体-蛋白质相互作用图。
J Chem Inf Model. 2011 Oct 24;51(10):2778-86. doi: 10.1021/ci200227u. Epub 2011 Oct 5.
10
Therapeutic potential of adenosine analogues and conjugates.腺苷类似物和缀合物的治疗潜力。
Pharmacol Rep. 2011;63(3):601-17. doi: 10.1016/s1734-1140(11)70573-4.